TGTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Tg Therapeutics Inc (TGTX).


$4.69B Market Cap.

As of 03/03/2025 5:00 PM ET (MRY) • Disclaimer

TGTX Market Cap. (MRY)


TGTX Shares Outstanding (MRY)


TGTX Assets (MRY)


Total Assets

$577.69M

Total Liabilities

$355.33M

Total Investments

$131.91M

TGTX Income (MRY)


Revenue

$329.00M

Net Income

$23.38M

Operating Expense

$248.59M

TGTX Cash Flow (MRY)


CF Operations

-$40.52M

CF Investing

-$1.04M

CF Financing

$128.53M

TGTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

TGTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$577,690,000 (75.28%)

$329,587,000 (70.27%)

$193,572,000 (-49.01%)

$379,629,000 (-39.32%)

Assets Current

$566,359,000 (78.13%)

$317,943,000 (88.94%)

$168,274,000 (-49.16%)

$330,965,000 (-45.90%)

Assets Non-Current

$11,331,000 (-2.69%)

$11,644,000 (-53.97%)

$25,298,000 (-48.01%)

$48,664,000 (250.05%)

Goodwill & Intangible Assets

$0 (0%)

$799,000 (0.00%)

$799,000 (0.00%)

$799,000 (0.00%)

Shareholders Equity

$222,364,000 (38.54%)

$160,502,000 (173.95%)

$58,587,000 (-75.30%)

$237,153,000 (-54.34%)

Property Plant & Equipment Net

$7,151,000 (-25.20%)

$9,560,000 (-11.66%)

$10,822,000 (-2.22%)

$11,068,000 (-6.55%)

Cash & Equivalents

$181,192,000 (92.31%)

$94,218,000 (-9.04%)

$103,577,000 (-65.49%)

$300,151,000 (-45.89%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$23,499,000 (290.61%)

$6,016,000 (1216.41%)

$457,000 (0.00%)

$457,000 (-25.08%)

Total Investments

$131,914,000 (5.89%)

$124,575,000 (73.56%)

$71,778,000 (39.62%)

$51,409,000 (-1.11%)

Investments Current

$131,106,000 (5.24%)

$124,575,000 (109.81%)

$59,374,000 (273.99%)

$15,876,000 (-69.46%)

Investments Non-Current

$808,000 (0%)

$0 (0%)

$12,404,000 (-65.09%)

$35,533,000 (0%)

Inventory

$110,458,000 (177.37%)

$39,823,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$129,185,000 (152.84%)

$51,093,000 (0%)

$0 (0%)

$1,389,000 (0%)

Trade & Non-Trade Payables

$58,296,000 (51.53%)

$38,471,000 (-8.44%)

$42,019,000 (-18.08%)

$51,294,000 (38.58%)

Accumulated Retained Earnings (Deficit)

-$1,529,194,000 (-0.98%)

-$1,514,361,000 (0.83%)

-$1,527,033,000 (-14.93%)

-$1,328,698,000 (-35.50%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$252,562,000 (130.97%)

$109,349,000 (34.21%)

$81,479,000 (4.99%)

$77,610,000 (92.55%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$975,000 (-95.60%)

Debt Non-Current

$252,562,000 (130.97%)

$109,349,000 (34.21%)

$81,479,000 (6.32%)

$76,635,000 (322.74%)

Total Liabilities

$355,326,000 (110.15%)

$169,085,000 (25.26%)

$134,985,000 (-5.26%)

$142,476,000 (34.04%)

Liabilities Current

$90,679,000 (68.80%)

$53,720,000 (0.98%)

$53,201,000 (-18.63%)

$65,384,000 (-25.32%)

Liabilities Non-Current

$264,647,000 (129.40%)

$115,365,000 (41.06%)

$81,784,000 (6.09%)

$77,092,000 (311.42%)

TGTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$329,004,000 (40.80%)

$233,662,000 (8290.02%)

$2,785,000 (-58.36%)

$6,689,000 (4300.66%)

Cost of Revenue

$38,486,000 (172.35%)

$14,131,000 (5232.45%)

$265,000 (-66.46%)

$790,000 (0%)

Selling General & Administrative Expense

$154,298,000 (25.75%)

$122,706,000 (75.28%)

$70,007,000 (-45.35%)

$128,090,000 (18.77%)

Research & Development Expense

$94,291,000 (23.75%)

$76,192,000 (-39.22%)

$125,352,000 (-43.68%)

$222,579,000 (34.17%)

Operating Expenses

$248,589,000 (24.98%)

$198,898,000 (1.81%)

$195,359,000 (-44.29%)

$350,669,000 (28.10%)

Interest Expense

$24,028,000 (90.47%)

$12,615,000 (23.79%)

$10,191,000 (80.76%)

$5,638,000 (-10.92%)

Income Tax Expense

$2,211,000 (466.92%)

$390,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$23,383,000 (84.52%)

$12,672,000 (106.39%)

-$198,335,000 (43.02%)

-$348,101,000 (-24.60%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$23,383,000 (84.52%)

$12,672,000 (106.39%)

-$198,335,000 (43.02%)

-$348,101,000 (-24.60%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$23,383,000 (84.52%)

$12,672,000 (106.39%)

-$198,335,000 (43.02%)

-$348,101,000 (-24.60%)

Weighted Average Shares

$145,317,418 (2.37%)

$141,955,112 (4.83%)

$135,411,258 (2.41%)

$132,222,753 (14.64%)

Weighted Average Shares Diluted

$160,336,051 (7.96%)

$148,508,465 (9.67%)

$135,411,258 (2.41%)

$132,222,753 (14.64%)

Earning Before Interest & Taxes (EBIT)

$49,622,000 (93.25%)

$25,677,000 (113.65%)

-$188,144,000 (45.06%)

-$342,463,000 (-25.42%)

Gross Profit

$290,518,000 (32.34%)

$219,531,000 (8611.55%)

$2,520,000 (-57.28%)

$5,899,000 (3780.92%)

Operating Income

$41,929,000 (103.21%)

$20,633,000 (110.70%)

-$192,839,000 (44.07%)

-$344,770,000 (-26.02%)

TGTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,036,000 (97.95%)

-$50,651,000 (-153.09%)

-$20,013,000 (-5928.01%)

-$332,000 (98.65%)

Net Cash Flow from Financing

$128,527,000 (76.78%)

$72,705,000 (18694.63%)

-$391,000 (-100.94%)

$41,419,000 (-93.91%)

Net Cash Flow from Operations

-$40,517,000 (-28.98%)

-$31,413,000 (82.17%)

-$176,170,000 (40.41%)

-$295,634,000 (-37.82%)

Net Cash Flow / Change in Cash & Cash Equivalents

$86,974,000 (1029.31%)

-$9,359,000 (95.24%)

-$196,574,000 (22.77%)

-$254,547,000 (-157.75%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$991,000 (98.04%)

-$50,651,000 (-153.27%)

-$19,999,000 (-29084.06%)

$69,000 (100.29%)

Capital Expenditure

-$45,000 (0%)

$0 (0%)

-$14,000 (96.51%)

-$401,000 (-12.32%)

Issuance (Repayment) of Debt Securities

$137,262,000 (449.05%)

$25,000,000 (2664.10%)

-$975,000 (-102.44%)

$40,000,000 (0%)

Issuance (Purchase) of Equity Shares

-$7,846,000 (-116.40%)

$47,830,000 (8090.07%)

$584,000 (-76.02%)

$2,435,000 (-99.64%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$42,541,000 (12.15%)

$37,933,000 (97.72%)

$19,185,000 (-68.69%)

$61,274,000 (-23.68%)

Depreciation Amortization & Accretion

$68,000 (-67.77%)

$211,000 (-30.36%)

$303,000 (7.45%)

$282,000 (78.48%)

TGTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

88.30% (-6.06%)

94.00% (3.87%)

90.50% (2.61%)

88.20% (-11.80%)

Profit Margin

7.10% (31.48%)

5.40% (100.08%)

-7121.50% (-36.84%)

-5204.10% (97.17%)

EBITDA Margin

15.10% (36.04%)

11.10% (100.16%)

-6744.70% (-31.85%)

-5115.60% (97.15%)

Return on Average Equity (ROAE)

12.40% (-3.88%)

12.90% (107.46%)

-173.00% (-71.12%)

-101.10% (20.14%)

Return on Average Assets (ROAA)

4.80% (2.13%)

4.70% (105.72%)

-82.10% (-7.32%)

-76.50% (11.25%)

Return on Sales (ROS)

15.10% (37.27%)

11.00% (100.16%)

-6755.60% (-31.95%)

-5119.80% (97.15%)

Return on Invested Capital (ROIC)

11.70% (-2.50%)

12.00% (108.67%)

-138.40% (84.15%)

-873.00% (75.84%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

188.13 (-0.87%)

189.78 (2442.07%)

-8.1 (-12.17%)

-7.22 (66.39%)

Price to Sales Ratio (P/S)

13.29 (28.13%)

10.38 (-98.20%)

575.19 (53.15%)

375.58 (-99.05%)

Price to Book Ratio (P/B)

21.07 (30.78%)

16.11 (-45.10%)

29.35 (156.27%)

11.45 (-13.05%)

Debt to Equity Ratio (D/E)

1.6 (51.76%)

1.05 (-54.30%)

2.3 (283.36%)

0.6 (193.17%)

Earnings Per Share (EPS)

0.16 (77.78%)

0.09 (106.16%)

-1.46 (44.49%)

-2.63 (-8.68%)

Sales Per Share (SPS)

2.26 (37.55%)

1.65 (7738.10%)

0.02 (-58.82%)

0.05 (5000.00%)

Free Cash Flow Per Share (FCFPS)

-0.28 (-26.24%)

-0.22 (83.01%)

-1.3 (41.89%)

-2.24 (-20.18%)

Book Value Per Share (BVPS)

1.53 (35.28%)

1.13 (161.20%)

0.43 (-75.86%)

1.79 (-60.16%)

Tangible Assets Book Value Per Share (TABVPS)

3.98 (71.63%)

2.32 (62.64%)

1.42 (-50.30%)

2.87 (-47.12%)

Enterprise Value Over EBIT (EV/EBIT)

96 (-3.03%)

99 (1200.00%)

-9 (-28.57%)

-7 (70.83%)

Enterprise Value Over EBITDA (EV/EBITDA)

95.41 (-2.85%)

98.2 (1192.26%)

-8.99 (-27.44%)

-7.05 (70.94%)

Asset Turnover

0.68 (-21.59%)

0.87 (7116.67%)

0.01 (-20.00%)

0.01 (0%)

Current Ratio

6.25 (5.52%)

5.92 (87.13%)

3.16 (-37.51%)

5.06 (-27.55%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$40,562,000 (-29.12%)

-$31,413,000 (82.17%)

-$176,184,000 (40.49%)

-$296,035,000 (-37.78%)

Enterprise Value (EV)

$4,740,986,553 (86.48%)

$2,542,330,047 (50.53%)

$1,688,886,470 (-30.04%)

$2,414,163,641 (-63.56%)

Earnings Before Tax (EBT)

$25,594,000 (95.94%)

$13,062,000 (106.59%)

-$198,335,000 (43.02%)

-$348,101,000 (-24.60%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$49,690,000 (91.94%)

$25,888,000 (113.78%)

-$187,841,000 (45.10%)

-$342,181,000 (-25.39%)

Invested Capital

$558,381,000 (92.41%)

$290,199,000 (147.03%)

$117,474,000 (29.23%)

$90,905,000 (297.00%)

Working Capital

$475,680,000 (80.03%)

$264,223,000 (129.61%)

$115,073,000 (-56.67%)

$265,581,000 (-49.33%)

Tangible Asset Value

$577,690,000 (75.70%)

$328,788,000 (70.56%)

$192,773,000 (-49.11%)

$378,830,000 (-39.37%)

Market Capitalization

$4,685,526,553 (81.18%)

$2,586,084,047 (50.41%)

$1,719,395,470 (-36.69%)

$2,715,919,641 (-60.29%)

Average Equity

$188,049,500 (91.32%)

$98,289,250 (-14.25%)

$114,622,250 (-66.71%)

$344,271,250 (55.98%)

Average Assets

$484,558,500 (79.65%)

$269,716,500 (11.67%)

$241,539,250 (-46.90%)

$454,853,750 (40.39%)

Invested Capital Average

$425,168,500 (99.38%)

$213,240,000 (56.81%)

$135,983,750 (246.64%)

$39,229,000 (419.21%)

Shares

155,665,334 (2.81%)

151,410,073 (4.18%)

145,341,967 (1.68%)

142,943,139 (8.71%)